Stifel Nicolaus analyst Shlomo Rosenbaum maintained a Buy rating on Clarivate (CLVT – Research Report) today and set a price target of $8.00.

GALWAY, Ireland, March 12, 2025 /PRNewswire/ -- TE Connectivity, a world leader in connectors and sensors, has been named ...

LONDON, March 12, 2025 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today revealed its 2025 ranked list of Top 100 Global Innovators – the ...

The CNRS has been selected for the prestigious Top 100 Global Innovators ranking published today by Clarivate. The CNRS is one of six French actors that have distinguished themselves among the top 100 ...

UC San Diego is one of only two University of California campuses included in the Clarivate ranking. UC Berkeley placed ...

Macroeconomic factors add another layer of uncertainty to Clarivate's outlook. The potential impact of broader economic trends on the company's business model and customer base remains a concern for ...

Macroeconomic factors add another layer of uncertainty to Clarivate's outlook. The potential impact of broader economic trends on the company's business model and customer base remains a concern ...

US stock futures surged on Monday, signaling a potential rebound from recent losses as investors assessed the impact of President ... Here are five major factors investors will be keeping an ...

Environmental health is the public health field that monitors and addresses physical, chemical, and biological factors that impact your health though they're not always within your direct control.

In this article, we are going to take a look at where Clarivate Plc (NYSE ... and industry shifts well before these factors are reflected in stock prices. When insiders buy shares of their own ...

Even so, HSV-1 can be passed to the genitals and HSV-2 can be passed to the mouth via oral sex. This article describes the different causes and risk factors for HSV-1 and HSV-2. It also explains who ...